Nuvilex, Inc. (OTCMKTS:NVLX) Jumps on Stock Hideout Mention, Awaits Conference

Nuvilex, Inc. (OTCMKTS:NVLX) staged a robust enough ride to attract pumpers, which will boost their record with a good mover. NVLX added more than 17% on Thursday, reaching $0.155 on buying volumes above $2.65 million. On Friday, NVLX opened with another strong gain, toward 17 cents.

NVLX was promoted in a total of 13 emails this month, with fees totaling a relatively low $23,000, but in a momentum-gaining ticker, even a little mention could have a higher effect. The latest email landed this Friday, from Stock Hideout, and may ensure a positive start of the week, with some doubts if this would not be followed by selling on Monday. That individual email was compensated with $5,000.

As for next week, NVLX has its ducks in a row, since it will very probably receive a boost in buying and price range. NVLX is scheduled to take part in the Phacilitate Cell & Gene Therapy Forum 2014m held in Washington, DC. Those events are usually very beneficial for pharmaceutical or medical companies, though the share price tends to correct once the good news are absorbed by the market.

Strangely, NVLX was briefly promoted last fall, with underwhelming results. But the new year proved a generally positive period for the medical and pharma sector, Of course, NVLX did not miss to ride the medical cannabis train, but so far the gains have not been as dramatic as bigger movers in the sector. NVLX hopes to apply its scientific potential in creating new treatments.

But at this price range, such bids are a bit too far in the future, and NVLX remains a company with very low revenues of just $12,000 and more than $1.5 million in quarterly net losses. On top of all, NVLX is diluted enough with more than 593 million shares outstanding, which also keep the price in a very low range.

Investors’ forums are extremely skeptical of the company that holds a bit below $200K cash, but has upward of $3.7 million current liabilities. The hype and noise surrounding the ticker are also taken as a bad sign. But for now, there seem to be enough adherents who enjoy at least the short-term potential.

FusionPharm, Inc. (OTCMKTS:FSPM) is giving an example of what happens when the climbing price goes out of breath. This ticker is making a small plateau at $3, unable to easily conquer a higher position as it comes under downward pressure. For now, FSPM is not inflated by promotion, and rises just based on the cannabis stock exuberance.

Life is now more difficult for recent fast mover GreenGro Technologies, Inc. (OTCMKTS:GRNH), as the much-demanded name slid down from its high positions, unable to conquer a dollar price. Now, GRNH is making a tentative trend a bit above 40 cents.

If you want to devote the next days to NVLX, keep in mind that this selection has shown habitual corrections of 50% or more within weeks. And after the extreme spikes based on the pot stock hype, the cuts come even faster and sharper, so avoid investing unaffordable sums.